Nearly 400 compounds displayed significant effects on at least two behavioral parameters in zebrafish with SCN2A or DYRK1A variants, according to a new study.
By Charles Q. Choi
www.thetransmitter.org/animal-model...
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.